Methods of Preparing Anti-human Papillomavirus Antigen T Cells Read more about Methods of Preparing Anti-human Papillomavirus Antigen T Cells Hong Kong42020015851.7Filed on 2020-09-10
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Read more about T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Japan2020-114090Filed on 2020-07-01
MODIFIED CELLS AND METHODS OF THERAPY Read more about MODIFIED CELLS AND METHODS OF THERAPY US Patent 11,266,692Filed on 2020-06-12
MODIFIED CELLS AND METHODS OF THERAPY Read more about MODIFIED CELLS AND METHODS OF THERAPY US Patent 11,925,664Filed on 2020-06-12
MODIFIED CELLS AND METHODS OF THERAPY Read more about MODIFIED CELLS AND METHODS OF THERAPY US Application 16/900,363Filed on 2020-06-12
Methods of Preparing Anti-human Papillomavirus Antigen T Cells Read more about Methods of Preparing Anti-human Papillomavirus Antigen T Cells China202010606868.1Filed on 2020-06-29
THALIDOMIDE ANALOGS AND METHODS OF USE Read more about THALIDOMIDE ANALOGS AND METHODS OF USE US Patent 10,836,721Filed on 2020-06-24
CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer Read more about CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer US Application 16/889,914Filed on 2020-06-02
Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases Read more about Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases US Patent 11,167,012Filed on 2019-07-29
T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY Read more about T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY Patent Cooperation TreatyPCT/US2020/045100Filed on 2020-08-06